Description: Panacea Acquisition Corp. II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California.
Home Page: panacea.ecor1cap.com/home/default.aspx
PANA Technical Analysis
357 Tehama Street
San Francisco,
CA
94103
United States
Phone:
415 966 0807
Officers
| Name | Title |
|---|---|
| Mr. Oleg Nodelman | Chairman & CEO |
| Mr. Scott Eric Perlen | Chief Financial Officer |
| Mr. Scott Platshon | Chief Operating Officer |
| Ms. Caroline Stout | Chief Investment Officer |
| Ms. Sarah Marriott | Sec. & Director |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-08-24 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |